prednisone has been researched along with Response Evaluation Criteria in Solid Tumors in 1 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Response Evaluation Criteria in Solid Tumors: An internationally recognized set of published rules used for evaluation of cancer treatment that define when tumors found in cancer patients improve, worsen, or remain stable during treatment. These criteria are based specifically on the response of the tumor(s) to treatment, and not on the overall health status of the patient resulting from treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sonpavde, G | 1 |
| Pond, GR | 1 |
| Plets, M | 1 |
| Tangen, CM | 1 |
| Hussain, MHA | 1 |
| Lara, PN | 1 |
| Goldkorn, A | 1 |
| Garzotto, MG | 1 |
| Mack, PC | 1 |
| Higano, CS | 1 |
| Vogelzang, NJ | 1 |
| Thompson, IM | 1 |
| Twardowski, PW | 1 |
| Van Veldhuizen, PJ | 1 |
| Agarwal, N | 1 |
| Carducci, MA | 1 |
| Monk, JP | 1 |
| Quinn, DI | 1 |
1 other study available for prednisone and Response Evaluation Criteria in Solid Tumors
| Article | Year |
|---|---|
Validation of the Association of RECIST Changes With Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated on SWOG Study S0421.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Controlle | 2017 |